He has been a pioneer in the development of minimally invasive therapies for benign prostate disease and has extensive experience in the management of prostate cancer. He has been a regular contributor at both National and International Meetings and has published extensively in major urological journals. He has extensive clinical trials experience in the areas of prostate cancer and benign prostate disease in various capacities ranging from site prinicipal investigator through to trial management committees membership of large NHMRC funded studies. He is on the Board of Directors of the Australian and New Zealand Urogenital and Prostate (ANZUP) Clinical Trials Group and also runs a busy clinical trials unit, Australian Clinical Trials (ACT) Pty Ltd.